Latest News

iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day

BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...

2022-06-06 12:20 6850

OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology

TOKYO, June 5, 2022 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has closed Series B2 financing from Asahi Kasei Medical Co., Ltd. OriCiro has advanced its busine...

2022-06-06 10:09 2510

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...

2022-06-06 09:00 2572

Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...

2022-06-06 09:00 2412

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...

2022-06-06 09:00 2641

Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform

SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the  Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...

2022-06-06 07:00 4503

LILYSILK Honors World Environment Day with Sustainable Living Initiatives

LOS ANGELES, June 5, 2022  /PRNewswire/ -- In conjunction with this year's World Environment Day , the world's leading silk brand LILYSILK is celebrating with zero-waste initiatives to champion a sustainable lifestyle, and contribute to a greener, better w...

2022-06-05 22:00 8441

Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements

BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...

2022-06-04 04:30 7150

Dogness (International) Corporation Closes $12 Million Offering

DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...

2022-06-04 01:48 8881

Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge

SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...

2022-06-03 23:45 7972

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022

SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...

2022-06-03 23:00 7154

ASIP Tech selected by Wizz Air for free inflight connectivity

NEW YORK, June 3, 2022 /PRNewswire/ -- AS-IP Tech (USOTC: IPTK) announced today it has signed an agreement with Wizz Air (LSE: WIZZ) to provide connectivity on its fleet of A320 and A321 UK based aircraft. In a world first, Wizz Air will integrate AS-IP Tech's fflya Bluetooth platform into its m...

2022-06-03 22:00 7195

JX Luxventure receives Nomination for the "Best Software Solution Provider" Award

HAIKOU, China, June 3, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a company delivering comprehensive products solutions to global elite families serviced by our business customers with business segments covering menswear, cross-border merchandise and tourism, announ...

2022-06-03 21:36 9481

Sylvox Outdoor TV Big Savings Event in Walmart+ Weekend

LOS ANGELES, June 3, 2022 /PRNewswire/ -- Sylvox is participating the first-everWalmart+ Weekend

2022-06-03 20:04 7195

ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

SAN FRANCISCO, June 3, 2022 /PRNewswire/ -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus ...

2022-06-03 20:00 7768

KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE

SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...

2022-06-03 19:00 9952

New Articles for May Issue of "KIZUNA," Official E-magazine of Japanese Government

TOKYO, June 3, 2022 /PRNewswire/ -- The Japanese government publishes new articles every month in an official e-magazine, "KIZUNA." Six new articles, published in May, are outlined below. Logo: https://kyodonewsprwire.jp/prwfile/release/M107127/202206022026/_prw_PI2fl_W13w7HMJ.jpg

2022-06-03 14:00 4840

CANACCORD GENUITY GROUP INC. REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS

Excluding significant items, quarterly earnings per common share of $0.52 (1) Excluding significant items, record full fiscal year earnings per common share of$2.51 (1) Fiscal 2022 common share year dividend payout increased 28% year-over-year TORONTO, June 3, 2022 /PRNewswire/ -- Canaccord Genuit...

2022-06-03 08:25 3761

Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform Announced - World Premiere

SHANGHAI, June 2, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals officially launched STAL (Super-Trillion Antibody Libraries) onJune 3, 2022, which is a super-trillion innovative antibody drug discovery platform of Sanyou's own intellectual property.

2022-06-03 08:00 3271

Jelenew and Stephane Rolland, tailor-made cycling pants-haute couture dress for star Kat Graham to attend the red carpet of the 75th Cannes Film Festival

Kat Graham, named the best-dressed stars at the 2022 Cannes Film Festival by Harper's Bazaar. WILMINGTON, Del. , June 2, 2022 /PRNewswire/ -- On May 28, actress Kat Graham made a stunning appearance on the red carpet of the closing ceremony of the 2022 Cannes Film Festival in Jelenew

2022-06-03 06:32 3450